55 results
HERDOO2 score to identify women with unprovoked venous thrombosis (VTE) at low risk of recurrent venous
thrombosis (VTE) at low risk ... from Kahn et al #Management ... #IM #PrimaryCare
Suspected sepsis: Summary of NICE guidlelines #Diagnosis #Management #EM #IM #PrimaryCare #Sepsis #NICE #Monitoring #BMJ
guidlelines #Diagnosis #Management ... #EM #IM #PrimaryCare
Assessing and referring complications following bariatric surgery #Management #Diagnosis #IM #PrimaryCare #Bariatrics #GastricBypass #BariatricSurgery #Complications #RouxEnY
bariatric surgery #Management ... #Diagnosis #IM ... #PrimaryCare #Bariatrics
Diabetic foot: Primary care assessment and monitoring #Management #PrimaryCare #Podiatry #DiabeticFoot #Diabetes #Foot #Risk #Screening #BMJ
and monitoring #Management ... #PrimaryCare #Podiatry ... Diabetes #Foot #Risk
Barrett's Esophagus

Risk Factors, Screening, Progression to Cancer, and Monitoring

#Barretts #Esophagus #RiskFactors #Screening #Progression #Monitoring #Management #PrimaryCare
Barrett's Esophagus Risk ... Progression #Monitoring #Management ... #PrimaryCare #surveillance
Medium Risk Aspirin Decision Aid for Primary Cardiovascular Prevention - MEDIUM / ELEVATED risk (range low
Medium Risk Aspirin ... MEDIUM / ELEVATED risk ... elevated - high) #Management ... #PrimaryCare #Aspirin
Early Breast Cancer - Management Algorithm

#breast #cancer #malignancy #algorithm #oncology #early
Early Breast Cancer ... - Management Algorithm ... #breast #cancer ... malignancy #algorithm #oncology
Myelodysplastic Syndrome (MD) - Diagnosis and Management Summary
myelo (marrow) -dys- (abnormal) -plastic (shape) = funny-shaped cells
Diagnosis and Management ... diagnosis and risk-stratification ... • Risks: infection ... acute leukemia Management ... treatment #hematology #oncology
Early Breast Cancer - Management Algorithm
 • Luminal A-like (ER+ and/or PR+, HER2- and low proliferation)
Early Breast Cancer ... - Management Algorithm ... 0111-2 #Early #Breast ... #Cancer #Management ... Algorithm #treatment #oncology
Who to test for BRCA 1/2?
Female Breast Cancer:
 • ≤ 45-50 years at diagnosis
 • Triple
Female Breast Cancer ... Jewish or other risk ... /2 >5% (as per risk ... #indications #oncology ... #Breast #Cancer